PR

Pankaj Raojibhai Patel

Director Director DIN 00028227
DIN 00028227 First appointment Jan 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2018
Shareholding value •••• Premium profile

About Pankaj Raojibhai Patel

Data last updated:

Pankaj Raojibhai Patel was a Director at Rakesh Healthcare Private Limited (2018–2020) and Director at S.G. Vet Care Private Limited (2018–2021). The companies operate in Pharma.

DIN 00028227
Primary Designation Director
Industry Pharma
First Appointment 24 Jan 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rakesh Healthcare Private Limited U24299GJ2018PTC104283
Director20 Sep 20182018₹3,674 (FY 2022)Active
S.G. Vet Care Private Limited U24232GJ2013PTC074898
Director24 Jan 20182013₹24.28 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rakesh Healthcare Private Limited
S.G. Vet Care Private Limited
Premium access

Shareholding and investment profile for Pankaj Raojibhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Raojibhai Patel

Pankaj Raojibhai Patel was first appointed on 24 Jan 2018 as Director at S.G. Vet Care Private Limited.

Pankaj Raojibhai Patel held 2 earlier board appointments: Rakesh Healthcare Private Limited (Director, 20 Sep 2018 to 02 Mar 2020); S.G. Vet Care Private Limited (Director, 24 Jan 2018 to 08 Mar 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available